Volume 25, Number 6—June 2019
Research Letter
Absence of Neospora caninum DNA in Human Clinical Samples, Spain
On This Page
Tables
Downloads
Article Metrics
Rafael Calero-Bernal
, Pilar Horcajo, Marta Hernández, Luis Miguel Ortega-Mora, and Isabel Fuentes
, Pilar Horcajo, Marta Hernández, Luis Miguel Ortega-Mora, and Isabel FuentesAbstract
Low antibody titers to Neospora caninum have been reported in humans, but infection has not been confirmed. We used N. caninum–specific PCR to test 600 clinical samples from patients with toxoplasmosis signs but Toxoplasma gondii–negative PCR results. We did not detect N. caninum DNA, demonstrating it is an unlikely opportunistic zoonotic agent.
The coccidian parasite Neospora caninum (Apicomplexa: Sarcocystidae) is a major abortifacient agent in ruminants, especially cattle. It is phylogenetically close to Toxoplasma gondii (1), a parasite of high prevalence in humans, but biologically different. N. caninum parasites have a restricted host range but can infect primates (2,3).
N. caninum infection causes neuromuscular disease in dogs and reproductive disorders in ruminants, causing fetal loss due to vertical transfer of parasites during acute infections or reactivation of chronic infections. Clinical neosporosis in animals resembles the disease outcome of toxoplasmosis (1).
N. caninum parasites have been successfully cultured in human cell lines, but low antibody titers of unconfirmed specificity against N. caninum have been reported in human serum samples (1,4,5). The significance of these findings is uncertain because neither parasite DNA nor viable parasites have been demonstrated in human tissues. Unconfirmed reports of N. caninum–specific antibodies in the human population (4,5) prompted us to test specifically for Neospora DNA in human clinical specimens and assess its possible role in human illness.
We obtained 600 DNA samples from a collection of anonymized human clinical samples from the National Registry of Biobanks (no. C.0004715) in Spain that were deemed exempt from a second ethics approval. Our criteria for selection included any pregnancy-related disorder affecting women or fetuses, toxoplasmosis-like clinical signs or suspicion of toxoplasmosis, and negative results for T. gondii–specific real-time PCR (6) and nested PCR (7) (Table).
We isolated total DNA using a QIAamp DNA Mini Kit (QIAGEN, https://www.qiagen.com) and used a single-tube nested PCR to amplify the N. caninum internal transcribed spacer 1 region using external primers NN1–NN2 and internal primers NP1–NP2, as previously described (8,9). We expected a diagnostic 249-bp fragment. In each batch of amplifications, positive PCR controls included genomic DNA of 10, 1, and 0.1 N. caninum tachyzoites. Using these PCR methods, we found that the analytical sensitivity was <1 tachyzoite of Neospora spp. or T. gondii.
We did not detect N. caninum–specific DNA in the samples analyzed. Previously, transplacental neosporosis was experimentally demonstrated in rhesus macaques (Macaca mulatta) in the United States (2,3). A literature review summarized reports of unconfirmed presence of antibodies against N. caninum in patients with neurologic disorders, pregnant women, and healthy people, including blood donors (1). Findings of N. caninum IgG in HIV-infected patients from Brazil and France (4,5) are of special interest because of possible association with T. gondii infections.
We believe N. caninum parasites are an unlikely opportunistic zoonotic agent. Application of direct methods for parasite detection in a greater number of samples from HIV-positive patients should complement unclear serologic findings to fully dispel suspicion of human neosporosis.
Dr. Calero-Bernal is a postdoctoral researcher at the Saluvet Research Group of the Complutense University, Madrid. His major research interests are Apicomplexan parasites of zoonotic interest, epidemiology of foodborne parasites, and molecular pathways in virulence and drug susceptibility in protozoans.
Acknowledgment
This work was supported by National Health Research Funds Project P13/01106. Carlos III Health Institute Spanish Ministry of Science and Innovation. R.C-B. is funded by Complutense University of Madrid, Madrid, Spain (grant no. CT65/16).
References
- Dubey JP, Hemphill A, Calero-Bernal R, Schares G. Neosporosis in animals. Boca Raton (FL): CRC Press; 2017.
- Barr BC, Conrad PA, Sverlow KW, Tarantal AF, Hendrickx AG. Experimental fetal and transplacental Neospora infection in the nonhuman primate. Lab Invest. 1994;71:236–42.PubMed
- Ho MS, Barr BC, Tarantal AF, Lai LT, Hendrickx AG, Marsh AE, et al. Detection of Neospora from tissues of experimentally infected rhesus macaques by PCR and specific DNA probe hybridization. J Clin Microbiol. 1997;35:1740–5.PubMed
- Lobato J, Silva DA, Mineo TW, Amaral JD, Segundo GR, Costa-Cruz JM, et al. Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders. Clin Vaccine Immunol. 2006;13:84–9. DOIPubMed
- Fuentes I, Rodriguez M, Domingo CJ, del Castillo F, Juncosa T, Alvar J. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol. 1996;34:2368–71.PubMed
Table
Cite This ArticleOriginal Publication Date: 4/30/2019
No hay comentarios:
Publicar un comentario